Literature DB >> 19444137

A survey of the practice of electroconvulsive therapy in Asia.

Worrawat Chanpattana1, Barry Alan Kramer, Girish Kunigiri, B N Gangadhar, Rungrueng Kitphati, Chittaranjan Andrade.   

Abstract

OBJECTIVE: To describe a comprehensive survey of the practice of electroconvulsive therapy (ECT) in Asia.
METHOD: Between 2001 and 2003, a 29-item questionnaire was sent to 977 psychiatric facilities in 45 Asian countries.
RESULTS: Completed questionnaires were returned by 334 (34.2%) institutions in 29 (64.4%) countries. Electroconvulsive therapy was available in 257 institutions in 23 countries. During the year before the survey, 39,875 patients (62% men) received a mean of 7.1 ECT treatments. Most patients (73.1%) were 18 to 44 years old; few were younger than 18 years (6.0%) or older than 64 years (4.4%). Indications for ECT were schizophrenia (41.8%), major depression (32.4%), mania (14.0%), catatonia (6.9%), drug abuse (1.8%), dysthymia (1.6%), and others. Brief-pulse ECT devices were used in only 115 (58.4%) of 197 institutions. Routine electroencephalographic monitoring was conducted in only 59 (23.0%) institutions. Bilateral electrode placement was invariable in 202 (78.6%) institutions. Unmodified ECT was administered to 22,194 (55.7%) patients at 141 (54.9%) institutions in 14 countries. Continuation ECT was available in only 115 (44.7%) institutions in 17 countries. No institution had a formal ECT training program.
CONCLUSIONS: The practice of ECT in Asia may seem suboptimal: schizophrenia, not depression, is the most common indication; most institutions offer sine-wave ECT; unmodified ECT is commonly administered; bilateral electrode placement is invariable in most institutions; electroencephalographic monitoring is uncommon; continuation ECT is infrequent; and no formal training in ECT is available. We speculate that the suboptimal practices reflect felt needs and ground realities in standards of medical care in developing countries rather than a misuse of ECT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19444137     DOI: 10.1097/YCT.0b013e3181a74368

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  26 in total

Review 1.  Somatic treatments for mood disorders.

Authors:  Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

2.  Electroconvulsive practice in Singapore: a cross-sectional national survey.

Authors:  Phern-Chern Tor; Verònica Gálvez; Aaron Ang; Johnson Fam; Herng-Nieng Chan; Sheng-Neng Tan; Colleen K Loo
Journal:  Singapore Med J       Date:  2019-06-14       Impact factor: 1.858

3.  Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder.

Authors:  Haihua Tian; Guangxue Li; Guoan Xu; Jimeng Liu; Xiaohan Wan; Jiao Zhang; Shuguang Xie; Jia Cheng; Shugui Gao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-02       Impact factor: 5.270

4.  Contemporary use and practice of electroconvulsive therapy worldwide.

Authors:  Kari Ann Leiknes; Lindy Jarosh-von Schweder; Bjørg Høie
Journal:  Brain Behav       Date:  2012-05       Impact factor: 2.708

5.  General Anaesthesia Protocols for Patients Undergoing Electroconvulsive Therapy: Retrospective analysis of 504 sessions over a five-year period at a tertiary care hospital in Oman.

Authors:  Aravind Narayanan; Chandar Lal; Hamed Al-Sinawi
Journal:  Sultan Qaboos Univ Med J       Date:  2017-03-30

6.  Electroconvulsive Therapy in Women: A Retrospective Study from a Mental Health Hospital in Turkey.

Authors:  Armağan Özdemir; Cana Aksoy Poyraz; Evrim Erten; Emre Çırakoğlu; Nesrin Tomruk
Journal:  Psychiatr Q       Date:  2016-12

7.  Use of ECT in Nepal: A One Year Study From the Country's Largest Psychiatric Facility.

Authors:  Sandip Subedi; Tapas Kumar Aich; Niru Sharma
Journal:  J Clin Diagn Res       Date:  2016-02-01

8.  Position statement and guidelines on unmodified electroconvulsive therapy.

Authors:  Chittaranjan Andrade; N Shah; P Tharyan; M S Reddy; M Thirunavukarasu; R A Kallivayalil; R Nagpal; N K Bohra; A Sharma; E Mohandas
Journal:  Indian J Psychiatry       Date:  2012-04       Impact factor: 1.759

9.  Why do we prescribe ECT to schizophrenia patients?

Authors:  Vivek H Phutane; Jagadisha Thirthalli; Muralidharan Kesavan; Naveen C Kumar; B N Gangadhar
Journal:  Indian J Psychiatry       Date:  2011-04       Impact factor: 1.759

Review 10.  Packages of care for depression in low- and middle-income countries.

Authors:  Vikram Patel; Gregory Simon; Neerja Chowdhary; Sylvia Kaaya; Ricardo Araya
Journal:  PLoS Med       Date:  2009-10-06       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.